These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18061845)

  • 1. Proteomics and diabetic nephropathy.
    Merchant ML; Klein JB
    Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic identification of urinary biomarkers of diabetic nephropathy.
    Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
    Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of kidney proteins in streptozotocin-induced diabetic rats in response to hypoglycemic fungal polysaccharides.
    Hwang HJ; Baek YM; Kim SW; Kumar GS; Cho EJ; Oh JY; Yun JW
    J Microbiol Biotechnol; 2007 Dec; 17(12):2005-17. PubMed ID: 18167449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum, liver, and kidney proteomic analysis for the alloxan-induced type I diabetic mice after insulin gene transfer of naked plasmid through electroporation.
    Diao WF; Chen WQ; Wu Y; Liu P; Xie XL; Li S; Shen PP; Ji J
    Proteomics; 2006 Nov; 6(21):5837-45. PubMed ID: 17022097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods of comparative proteomic profiling for disease diagnostics.
    Steel LF; Haab BB; Hanash SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):275-84. PubMed ID: 15652816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder.
    Jain S; Rajput A; Kumar Y; Uppuluri N; Arvind AS; Tatu U
    J Assoc Physicians India; 2005 Jun; 53():513-20. PubMed ID: 16121805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic methods for biomarker discovery in urine.
    Wilkey DW; Merchant ML
    Semin Nephrol; 2007 Nov; 27(6):584-96. PubMed ID: 18061841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential serum proteomic analysis in a model of metabolic disease.
    Matsumura T; Suzuki T; Kada N; Aizawa K; Munemasa Y; Nagai R
    Biochem Biophys Res Commun; 2006 Dec; 351(4):965-71. PubMed ID: 17097053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of proteomic-based study of the kidney, urine, plasma, and uremic ultrafiltrate. Potential applications of the results in nephrology].
    Opatrný K
    Vnitr Lek; 2004 Jul; 50(7):556-63. PubMed ID: 15323265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Liu H; Hou X; Cheng J
    Nephrology (Carlton); 2009 Apr; 14(3):332-7. PubMed ID: 19143942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of high dose thiamine on the levels of urinary protein biomarkers in diabetes mellitus type 2.
    Riaz S; Skinner V; Srai SK
    J Pharm Biomed Anal; 2011 Mar; 54(4):817-25. PubMed ID: 21130593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome analysis of serum from type 2 diabetics with nephropathy.
    Kim HJ; Cho EH; Yoo JH; Kim PK; Shin JS; Kim MR; Kim CW
    J Proteome Res; 2007 Feb; 6(2):735-43. PubMed ID: 17269729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
    Sharma K; Lee S; Han S; Lee S; Francos B; McCue P; Wassell R; Shaw MA; RamachandraRao SP
    Proteomics; 2005 Jul; 5(10):2648-55. PubMed ID: 15984045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of urinary protein pattern in type 1 diabetic adolescents with early diabetic nephropathy by a novel combined proteome analysis.
    Meier M; Kaiser T; Herrmann A; Knueppel S; Hillmann M; Koester P; Danne T; Haller H; Fliser D; Mischak H
    J Diabetes Complications; 2005; 19(4):223-32. PubMed ID: 15993357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics and diabetic retinopathy.
    Merchant ML; Klein JB
    Clin Lab Med; 2009 Mar; 29(1):139-49. PubMed ID: 19389556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomic profiling identifies new renal targets of copper(II)-selective chelation in the reversal of diabetic nephropathy in rats.
    Gong D; Chen X; Middleditch M; Huang L; Vazhoor Amarsingh G; Reddy S; Lu J; Zhang S; Ruggiero K; Phillips AR; Cooper GJ
    Proteomics; 2009 Sep; 9(18):4309-20. PubMed ID: 19634143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics of mitochondrial inner and outer membranes.
    Distler AM; Kerner J; Hoppel CL
    Proteomics; 2008 Oct; 8(19):4066-82. PubMed ID: 18763707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin.
    Zamora DO; Riviere M; Choi D; Pan Y; Planck SR; Rosenbaum JT; David LL; Smith JR
    Mol Vis; 2007 Oct; 13():2058-65. PubMed ID: 18079679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.